Skip to main content
OpenTrials

Clinical trial condition

Growth Hormone Disorder

Explore clinical trials studying Growth Hormone Disorder. Study availability and eligibility vary by location and protocol.

36 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Growth Hormone Disorder trial results

Completed

Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

NCT02616562

Conditions
Growth Hormone Deficiency in Children, Growth Hormone Disorder
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles - Endocrinology Los Angeles, California, United States
  • Mattel Children's Hospital at UCLA Los Angeles, California, United States
  • Valley Children's Hospital Madera, California, United States
View all 89 locations
View Trial Details
Completed

Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients

NCT01562834

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Novo Nordisk Investigational Site Angers, France
  • Novo Nordisk Investigational Site Boisguillaume, France
  • Novo Nordisk Investigational Site Brest, France
  • Novo Nordisk Investigational Site Caen, France
View all 24 locations
View Trial Details
Completed

A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency

NCT01706783

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Novo Nordisk Investigational Site Århus C, Denmark
  • Novo Nordisk Investigational Site København Ø, Denmark
  • Novo Nordisk Investigational Site Odense, Denmark
  • Novo Nordisk Investigational Site Stockholm, Sweden
View Trial Details
Completed

A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency

NCT01973244

Conditions
Growth Hormone Deficiency in Children, Growth Hormone Disorder
Locations
  • Novo Nordisk Investigational Site Graz, Austria
  • Novo Nordisk Investigational Site Linz, Austria
  • Novo Nordisk Investigational Site Vienna, Austria
  • Novo Nordisk Investigational Site Brussels, Belgium
View all 22 locations
View Trial Details
Completed

Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.

NCT02229851

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Aurora, Colorado, United States
View all 117 locations
View Trial Details
Completed

A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency

NCT03075644

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Novo Nordisk Investigational Site Bunkyo-ku, Tokyo, Japan
  • Novo Nordisk Investigational Site Chiba-shi, Chiba, Japan
  • Novo Nordisk Investigational Site Fukuoka, Japan
  • Novo Nordisk Investigational Site Kagoshima, Japan
View Trial Details
Completed

A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency

NCT02382939

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Novo Nordisk Investigational Site Århus C, Denmark
  • Novo Nordisk Investigational Site København Ø, Denmark
  • Novo Nordisk Investigational Site Odense, Denmark
  • Novo Nordisk Investigational Site Angers, France
View all 28 locations
View Trial Details

Related conditions